Acne drug Roaccutane linked to depression

	Tweet

A drug commonly used to treat severe acne can lead to depressive behaviour in mice, according to research published in the journal Neuropsychopharmacology.

Since the drug’s introduction in the early 1980s there have been controversial reports of depression and suicidal behaviour that may have occurred in some people taking Roaccutane.

This has led to the drug’s manufacturers, Roche, including a warning in the product information that taking the medication may cause depression, psychosis and suicidal behaviour. 

However, the chemical mechanism by which this might happen has never been established.

In new independent research, scientists at the universities of Bath and Texas at Austin gave Roaccutane to mice over a period of six weeks, and then monitored the rodents’ behaviour.

They found that whilst there was no change in the physical abilities of the mice, the rodents spent significantly more time immobile in a range of laboratory assessments designed to test their stress responsiveness - suggesting that administration of Roaccutane increases depression-related behaviour in mice.

“Without more research it is difficult to say for sure whether the same link applies to people taking the drug,” said Dr Sarah Bailey from the Department of Pharmacy and Pharmacology at the University of Bath.

“However, establishing a link between the active molecules within the drug and a change in depression-related behaviour, albeit in mice, is an important step forward in our understanding of the effects of this drug in the wider context of brain function.

“To date the only evidence for any link with patients has come from individual case reports and such patient data is complicated by the psychosocial effects of having severe acne.

“This laboratory evidence provides a useful model for future research into Roaccutane and understanding how this family of compounds affects the brain.”

Roaccutane belongs to a group of medicines called retinoids - vitamin A-related compounds known to affect development of the nervous system. For this reason Roaccutane is not prescribed to pregnant women.

“Previously scientists thought that retinoids were only important in the development of the nervous system. Now there is a growing interest in retinoids as regulators of different aspects of brain function in adults,” said Dr Bailey.

“While our research is the first to demonstrate that retinoids are capable of influencing depression-related behaviours, these compounds may also play a role in the pathology of Alzheimer’s disease and schizophrenia”.

This research was conducted through a collaboration between Dr. Sarah Bailey (Department of Pharmacy and Pharmacology, University of Bath) and Dr. Michelle Lane (Department of Human Ecology, Division of Nutritional Sciences, at the University of Texas at Austin) and funded by the University of Texas at Austin.

http://www.bath.ac.uk

RELATED STORIES:
Strong Drugs without the Addiction   Novartis Warns of Skin Problems with Epilepsy Drug   Los Angeles clinic used wrong drug for syphilis   About 1.2 million people use stimulants for non-medical reasons, government finds   Expert panel urges limited use of J&J heart drug   COX-2 drugs may suppress immune function-study   Drug used worldwide doubles risk of kidney failure   J&J recalls drug after glass found in bottle   Preventing avoidable opioid-related deaths top priority for pain medicine field   More U.S. doctors facing charges over drug abuse   Scientists give more evidence of Vioxx heart risks   Celecoxib Can Adversely Affect Heart Rhythm

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]